Financial Statements and Related Announcement::Third Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
12-Feb-2022 01:27:34
Status
New
Announcement Sub Title
Third Quarter Results
Announcement Reference
SG220212OTHRWLJB
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
11/02/2022 00:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Unaudited Financial Results (Standalone and Consolidated) for the Third Quarter and Nine Months ended December 31, 2021.

Additional Details

For Financial Period Ended
31/12/2021

Attachments

SGX_RESULT_FINAL_11022022.pdf
Total size =17775K